Literature DB >> 6125633

Central actions of beta-adrenoceptor blocking drugs in man.

L Patel, P Turner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6125633     DOI： 10.1002/med.2610010405

Source DB:  PubMed          Journal:  Med Res Rev        ISSN： 0198-6325            Impact factor:   12.944


× No keyword cloud information.
  14 in total

1.  Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects--a comparison with atenolol.

Authors:  E S Dimenäs; C G Dahlöf; B Heibel; R G Moore; B K Olofsson; G E Westergren; P W Lücker
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Therapeutic uses of beta-adrenoceptor blocking drugs in the central nervous system in man.

Authors:  P Turner
Journal:  Postgrad Med J       Date:  1989-01       Impact factor: 2.401

Review 3.  Memory function--effects of different antihypertensive drugs.

Authors:  P J Richardson; M A Wyke
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

5.  Effect of beta-blockers on psychomotor performance in normal volunteers.

Authors:  T A Betts; R Knight; A Crowe; A Blake; P Harvey; D Mortiboy
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 6.  Psychomotor performance and antihypertensive treatment.

Authors:  L Kalra; C G Swift; S H Jackson
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

Review 7.  CNS-related (side-)effects of beta-blockers with special reference to mechanisms of action.

Authors:  W P Koella
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Atenolol offers better protection than clonidine against cardiac injury in kainic acid-induced status epilepticus.

Authors:  M I Read; J C Harrison; D S Kerr; I A Sammut
Journal:  Br J Pharmacol       Date:  2015-08-24       Impact factor: 8.739

9.  Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man.

Authors:  J I Nurnberger; S Simmons-Alling; L Kessler; S Jimerson; J Schreiber; E Hollander; C A Tamminga; N S Nadi; D S Goldstein; E S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Receptor occupancy in lumbar CSF as a measure of the antagonist activity of atenolol, metoprolol and propranolol in the CNS.

Authors:  T Kaila; R Marttila
Journal:  Br J Clin Pharmacol       Date:  1993-05       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.